Contribution of innate immune cells to pathogenesis of severe influenza virus infection

Clinical Science

Volumn 131, Issue 4, 2017, Pages 269-283

  Cole, Suzanne L ^a   Ho, Ling Pei ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Infection; Influenza; Innate immunity

Indexed keywords

ADOPTIVE TRANSFER; ARTICLE; CELLULAR IMMUNITY; DENDRITIC CELL; DISEASE SEVERITY; EFFECTOR CELL; GENETIC POLYMORPHISM; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFECTION CONTROL; INFLUENZA; INNATE IMMUNITY; LYMPHOID CELL; MACROPHAGE; MONOCYTE; MUCOSAL-ASSOCIATED INVARIANT T CELL; NATURAL KILLER CELL; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; IMMUNOLOGY; INFLUENZA A VIRUS; ORTHOMYXOVIRUS INFECTION;

ANIMALS; DENDRITIC CELLS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; INFLUENZA A VIRUS; INFLUENZA, HUMAN; KILLER CELLS, NATURAL; MACROPHAGES; MONOCYTES; NEUTROPHILS; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 85014082966     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20160484     Document Type: Article

References (190)

1. WHO. (2014), Influenza Fact Sheet no. 211, 6 May 2015.
2. Simonsen, L., Clarke, M.J., Schonberger, L.B., Arden, N.H., Cox, N.J., Fukuda, K. (1998) Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J. Infect. Dis. 178, 53-60.
3. Wu, Y., Tefsen, B., Shi, Y. and Gao, G.F. (2014) Bat-derived influenza-like viruses H17N10 and H18N11. Trends Microbiol. 22, 183-191.
4. Tong, S., Zhu, X., Li, Y., Shi, M., Zhang, J., Bourgeois, M. et al. (2013) New world bats harbor diverse influenza A viruses. PLoS Pathog. 9, e1003657.
5. Hay, A.J., Gregory, V., Douglas, A.R. and Lin, Y.P. (2001) The evolution of human influenza viruses. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356, 1861-1170
6. Webster, R.G., Bean, W.J., Gorman, O.T., Chambers, T.M. and Kawaoka, Y. (1992) Evolution and ecology of influenza A viruses. Microbiol. Mol. Biol. Rev. 56, 152-179.
7. Taubenberger, J.K. and Morens, D.M. (2010) Influenza: the once and future pandemic. Public Health Rep. 125 (Suppl. 3), 16-26.
8. Webster, R.G., Peiris, M., Chen, H. and Guan, Y. (2006) H5N1 outbreaks and enzootic influenza. Emerg. Infect. Dis. 12, 3-8.
9. Cowling, B.J., Jin, L., Lau, E.HY., Liao, Q., Wu, P., Jiang, H. et al. (2013) Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet 382, 129-137.
10. Claas, E.C., Osterhaus, A., van Beek, R., De Jong, J.C., Rimmelzwaan, G.F., Senne, D.A. et al. (1998) Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351, 472-477.
11. Gao, H.N., Lu, H.Z., Cao, B., Du, B., Shang, H., Gan, J.H. et al. (2013) Clinical findings in 111 cases of influenza A (H7N9) virus infection. N. Engl. J. Med. 368, 2277-2285.
12. WHO. (2016), Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2016 http://www.who.int/influenza/human_animal_ interface/EN_GIP_20160404cumulativenumberH5N1cases. pdf?ua=1.
13. Powell, T.J., Fox, A., Peng, Y., Quynh Mai le, T., Lien, V.T., Hang, N.L. et al. (2012) Identification of H5N1-specific T-cell responses in a high-risk cohort in vietnam indicates the existence of potential asymptomatic infections. J. Infect. Dis. 205, 20-27.
14. Wang, T.T., Parides, M.K. and Palese, P. (2012) Seroevidence for H5N1 influenza infections in humans: meta-analysis. Science 335, 1463.
15. Herfst, S., Schrauwen, E.J., Linster, M., Chutinimitkul, S., de Wit, E., Munster, V.J. et al. (2012) Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336, 1534-1541.
16. Imai, M., Watanabe, T., Hatta, M., Das, S.C., Ozawa, M., Shinya, K. et al. (2012) Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486, 420-428.
17. McKimm-Breschkin, J.L. (2013) Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance. Influenza Other Respir. Viruses 7 (Suppl. 1), 25-36.
18. Simonsen, L., Clarke, M.J., Schonberger, L.B., Arden, N.H., Cox, N.J. and Fukuda, K. (1998) Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J. Infect. Dis. 178, 53-60.
19. Opie, E.L., Blake, F.G. and Rivers, T.M. (2001) The pathology and bacteriology of pneumonia following influenza. Epidemic Respiratory Disease: The Pneumonias and Other Infections of the Respiratory Tract Accompanying Influenza and Measles (Opie, E.L., Blake, F.G., Small, J.C. and Rivers, T.M., eds), pp. 107-281, C.V. Mosby Co., St. Louis.
20. Short, K.R., Kroeze, E.J., Fouchier, R.A. and Kuiken, T. (2014) Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect. Dis. 14, 57-69.
21. Wang, Z., Zhang, A., Wan, Y., Liu, X., Qiu, C., Xi, X. et al. (2014) Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc. Natl. Acad. Sci. U.S.A. 111, 769-774.
22. Gao, R., Bhatnagar, J., Blau, D.M., Greer, P., Rollin, D.C., Denison, A.M. et al. (2013) Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): role of the host immune response in pathogenesis. Am. J. Pathol. 183, 1258-1268.
23. de Jong, M.D., Simmons, C.P., Thanh, T.T., Hien, V.M., Smith, G.J., Chau, T.N. et al. (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12, 1203-1207.
24. Couceiro, J.N., Paulson, J.C. and Baum, L.G. (1993) Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res. 29, 155-165.
25. Auewarakul, P., Suptawiwat, O., Kongchanagul, A., Sangma, C., Suzuki, Y., Ungchusak, K. et al. (2007) An avian influenza H5N1 virus that binds to a human-type receptor. J. Virol. 81, 9950-9955.
26. van Riel, D., den Bakker, M.A., Leijten, L.M., Chutinimitkul, S., Munster, V.J., de Wit, E. et al. (2010) Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses. Am. J. Pathol. 176, 1614-1618.
27. Fehrenbach, H. (2001) Alveolar epithelial type II cell: defender of the alveolus revisited. Respir. Res. 2, 33-46.
28. Sharma, A.K., Fernandez, L.G., Awad, A.S., Kron, I.L. and Laubach, V.E. (2007) Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-alpha during pulmonary ischemia-reperfusion injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L105-L113.
29. Iwasaki, A. and Pillai, P.S. (2014) Innate immunity to influenza virus infection. Nat. Rev. Immunol. 14, 315-328.
30. Hogner, K., Wolff, T., Pleschka, S., Plog, S., Gruber, A.D., Kalinke, U. et al. (2013) Macrophage-expressed IFN-beta contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS Pathog. 9, e1003188.
31. Kallfass, C., Lienenklaus, S., Weiss, S. and Staeheli, P. (2013) Visualizing the beta interferon response in mice during infection with influenza A viruses expressing or lacking nonstructural protein 1. J. Virol. 87, 6925-6930.
32. Jewell, N.A., Vaghefi, N., Mertz, S.E., Akter, P., Peebles, Jr, R.S., Bakaletz, L.O. et al. (2007) Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo. J. Virol. 81, 9790-9800.
33. Katze, M.G., He, Y. and Gale, Jr, M. (2002) Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2, 675-687.
34. Davidson, S., Crotta, S., McCabe, T.M. and Wack, A. (2014) Pathogenic potential of interferon aß in acute influenza infection. Nat. Commun. 5, 3864.
35. Lee, S.M., Cheung, C.Y., Nicholls, J.M., Hui, K.P., Leung, C.Y., Uiprasertkul, M. et al. (2008) Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. J. Infect. Dis. 198, 525-535.
36. Veckman, V., Osterlund, P., Fagerlund, R., Meĺen, K., Matikainen, S. and Julkunen, I. (2006) TNF-a and IFN-a enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. Virology 345, 96-104.
37. Chan, M.C., Cheung, C.Y., Chui, W.H., Tsao, S.W., Nicholls, J.M., Chan, Y.O. et al. (2005) Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir. Res. 6,.
38. Leung, Y.H., Nicholls, J.M., Ho, C.K., Sia, S.F., Mok, C.K., Valkenburg, S.A. et al. (2014) Highly pathogenic avian influenza A H5N1 and pandemic H1N1 virus infections have different phenotypes in Toll-like receptor 3 knockout mice. J. Gen. Virol.(Pt 9), 1870-1879.
39. Hui, K.P., Lee, S.M., Cheung, C.Y., Mao, H., Lai, A.K., Chan, R.W. et al. (2011) H5N1 influenza virus-induced mediators upregulate RIG-I in uninfected cells by paracrine effects contributing to amplified cytokine cascades. J. Infect. Dis. 204, 1866-1878.
40. Baskin, C.R., Bielefeldt-Ohmann, H., Tumpey, T.M., Sabourin, P.J., Long, J.P., Garćia-Sastre, A. et al. (2009) Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc. Natl. Acad. Sci. U.S.A. 106, 3455-3460.
41. Yona, S., Kim, K.W., Wolf, Y., Mildner, A., Varol, D., Breker, M. et al. (2013) Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38, 79-91.
42. Parihar, A., Eubank, T.D. and Doseff, A.I. (2010) Monocytes and macrophages regulate immunity through dynamic networks of survival and cell death. J. Innate Immun. 2, 204-215.
43. Tsou, C.L., Peters, W., Si, Y., Slaymaker, S., Aslanian, A.M., Weisberg, S.P. et al. (2007) Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117, 902-909.
44. Perera, L.P. and Waldmann, T.A. (1998) Activation of human monocytes induces differential resistance to apoptosis with rapid down regulation of caspase-8/FLICE. Proc. Natl. Acad. Sci. U.S.A. 95, 14308-14313.
45. Herold, S., von Wulffen, W., Steinmueller, M., Pleschka, S., Kuziel, W.A., Mack, M., Srivastava, M., Seeger, W., Maus, U.A. and Lohmeyer, J. (2006) Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules. J. Immunol. 177, 1817-1824.
46. Sprenger, H., Meyer, R.G., Kaufmann, A., Bussfeld, D., Rischkowsky, E. and Gemsa, D. (1996) Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection. J. Exp. Med. 184, 1191-1196.
47. Lin, K.L., Suzuki, Y., Nakano, H., Ramsburg, E. and Gunn, M.D. (2008) CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J. Immunol. 180, 2562-2572.
48. Lin, S.J., Lo, M., Kuo, R.L., Shih, S.R., Ojcius, D.M., Lu, J. et al. (2014) The pathological effects of CCR2+ inflammatory monocytes are amplified by an IFNAR1-triggered chemokine feedback loop in highly pathogenic influenza infection. J. Biomed. Sci. 21, 99.
49. Dawson, T.C., Beck, M.A., Kuziel, W.A., Henderson, F. and Maeda, N. (2000) Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am. J. Pathol. 156, 1951-1959.
50. Aldridge, Jr, J.R., Moseley, C.E., Boltz, D.A., Negovetich, N.J., Reynolds, C., Franks, J. et al. (2009) TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc. Natl. Acad. Sci. U.S.A. 106, 5306-5311.
51. Cook, D.N., Beck, M.A., Coffman, T.M., Kirby, S.L., Sheridan, J.F., Pragnell, I.B. et al. (1995) Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269, 1583-1585.
52. Herold, S., Steinmueller, M., von Wulffen, W., Cakarova, L., Pinto, R., Pleschka, S. et al. (2008) Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J. Exp. Med. 205, 3065-3077.
53. Cao, W., Taylor, A.K., Biber, R.E., Davis, W.G., Kim, J.H., Reber, A.J. et al. (2012) Rapid differentiation of monocytes into type I IFN-producing myeloid dendritic cells as an antiviral strategy against influenza virus infection. J. Immunol. 189, 2257-2265.
54. Perrone, L.A., Plowden, J.K., Garcia-Sastre, A., Katz, J.M. and Tumpey, T.M. (2008) H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog. 4, e1000115.
55. Cheung, C.Y., Poon, L.L., Lau, A.S., Luk, W., Lau, Y.L., Shortridge, K.F. et al. (2002) Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360, 1831-1837.
56. Voudoukis, E., Pappas, A., Panoutsopoulos, A., Xynos, K., Rozi, F., Giannakopoulou, K. et al. (2011) Novel influenza A (H1N1) infection vs. common influenza-like illness: a prospective study. Med. Sci. Monit. 17, CR185-CR188.
57. Giamarellos-Bourboulis, E.J., Raftogiannis, M., Antonopoulou, A., Baziaka, F., Koutoukas, P., Savva, A. et al. (2009) Effect of the novel influenza A (H1N1) virus in the human immune system. PLoS One 4, e8393.
58. Gill, M.A., Long, K., Kwon, T., Muniz, L., Mejias, A., Connolly, J. et al. (2008) Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza virus or respiratory syncytial virus infection. J. Infect. Dis. 198, 1667-1676.
59. Oshansky, C.M., Gartland, A.J., Wong, S.S., Jeevan, T., Wang, D., Roddam, P.L. et al. (2014) Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load. Am. J. Respir. Crit. Care Med. 189, 449-462.
60. Chen, J., Cui, G., Lu, C., Ding, Y., Gao, H., Zhu, Y. et al. (2016) Severe infection with avian influenza A virus is associated with delayed immune recovery in survivors. Medicine 95, e2606.
61. Diao, H., Cui, G., Wei, Y., Chen, J., Zuo, J., Cao, H. et al. (2014) Severe H7N9 infection is associated with decreased antigen-presenting capacity of CD14+ cells. PLoS One 9, e92823.
62. Gomez Perdiguero, E., Klapproth, K., Schulz, C., Busch, K., Azzoni, E., Crozet, L. et al. (2015) Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 518, 547-551.
63. Guilliams, M., De Kleer, I., Henri, S., Post, S., Vanhoutte, L., De Prijck, S. et al. (2013) Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J. Exp. Med. 210, 1977-1992.
64. Schneider, C., Nobs, S.P., Kurrer, M., Rehrauer, H., Thiele, C. and Kopf, M. (2014) Induction of the nuclear receptor PPAR-gamma by the cytokine GM-CSF is critical for the differentiation of fetal monocytes into alveolar macrophages. Nat. Immunol. 15, 1026-1037.
65. Hussell, T. and Bell, T.J. (2014) Alveolar macrophages: plasticity in a tissue-specific context. Nat. Rev. Immunol. 14, 81-93.
66. Tumpey, T.M., Garcia-Sastre, A., Taubenberger, J.K., Palese, P., Swayne, D.E., Pantin-Jackwood, M.J. et al. (2005) Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J. Virol. 79, 14933-14944.
67. Tate, M.D., Pickett, D.L., van Rooijen, N., Brooks, A.G. and Reading, P.C. (2010) Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J. Virol. 84, 7569-7580.
68. Purnama, C., Ng, S.L., Tetlak, P., Setiagani, Y.A., Kandasamy, M., Baalasubramanian, S. et al. (2014) Transient ablation of alveolar macrophages leads to massive pathology of influenza infection without affecting cellular adaptive immunity. Eur. J. Immunol. 44, 2003-2012.
69. Schneider, C., Nobs, S.P., Heer, A.K., Kurrer, M., Klinke, G., van Rooijen, N. et al. (2014) Alveolar macrophages are essential for protection from respiratory failure and associated morbidity following influenza virus infection. PLoS Pathog. 10, e1004053.
70. Huang, F.F., Barnes, P.F., Feng, Y., Donis, R., Chroneos, Z.C., Idell, S. et al. (2011) GM-CSF in the lung protects against lethal influenza infection. Am. J. Respir. Crit. Care Med. 184, 259-268.
71. Ghoneim, H.E., Thomas, P.G. and McCullers, J.A. (2013) Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections. J. Immunol. 191, 1250-1259.
72. Hashimoto, D., Chow, A., Noizat, C., Teo, P., Beasley, M.B., Leboeuf, M. et al. (2013) Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 38, 792-804.
73. Nakajima, N., Van Tin, N., Sato, Y., Thach, H.N., Katano, H., Diep, P.H. et al. (2013) Pathological study of archival lung tissues from five fatal cases of avian H5N1 influenza in Vietnam. Mod. Pathol. 26, 357-369.
74. Nicholls, J.M., Chan, M.C., Chan, W.Y., Wong, H.K., Cheung, C.Y., Kwong, D.L. et al. (2007) Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat. Med. 13, 147-149.
75. Lee, S.M., Dutry, I. and Peiris, J.S. (2012) Editorial: macrophage heterogeneity and responses to influenza virus infection. J. Leukoc. Biol. 92, 1-4.
76. Lee, S.M., Gardy, J.L., Cheung, C.Y., Cheung, T.K., Hui, K.P., Ip, N.Y. et al. (2009) Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages. PLoS One 4, e8072.
77. Hui, K.P., Lee, S.M., Cheung, C.Y., Ng, I.H., Poon, L.L., Guan, Y. et al. (2009) Induction of proinflammatory cytokines in primary human macrophages by influenza A virus (H5N1) is selectively regulated by IFN regulatory factor 3 and p38 MAPK. J. Immunol. 182, 1088-1098.
78. Geiler, J., Michaelis, M., Sithisarn, P. and Cinatl, Jr, J. (2011) Comparison of pro-inflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses. Med. Microbiol. Immunol. 200, 53-60.
79. Monteerarat, Y., Sakabe, S., Ngamurulert, S., Srichatraphimuk, S., Jiamtom, W., Chaichuen, K. et al. (2010) Induction of TNF-alpha in human macrophages by avian and human influenza viruses. Arch. Virol. 155, 1273-1279.
80. Sakabe, S., Iwatsuki-Horimoto, K., Takano, R., Nidom, C.A., Le, Mt, Nagamura-Inoue, T. et al. (2011) Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses. J. Gen. Virol.(Pt 6), 1428-1434.
81. van Riel, D., Leijten, L.M., van der Eerden, M., Hoogsteden, H.C., Boven, L.A., Lambrecht, B.N. et al. (2011) Highly pathogenic avian influenza virus H5N1 infects alveolar macrophages without virus production or excessive TNF-alpha induction. PLoS Pathog 7, e1002099.
82. Yu, W.C., Chan, R.W., Wang, J., Travanty, E.A., Nicholls, J.M., Peiris, J.S., Mason, R.J. and Chan, M.C. (2011) Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses. J. Virol. 85, 6844-6855.
83. Friesenhagen, J., Boergeling, Y., Hrincius, E., Ludwig, S., Roth, J. and Viemann, D. (2012) Highly pathogenic avian influenza viruses inhibit effective immune responses of human blood-derived macrophages. J. Leukoc. Biol. 92, 11-20.
84. Cline, T.D., Karlsson, E.A., Seufzer, B.J. and Schultz-Cherry, S. (2013) The hemagglutinin protein of highly pathogenic H5N1 influenza viruses overcomes an early block in the replication cycle to promote productive replication in macrophages. J. Virol. 87, 1411-1419.
85. van Helden, M.J. and Lambrecht, B.N. (2013) Dendritic cells in asthma. Curr. Opin. Immunol. 25, 745-754.
86. Heath, W.R. and Carbone, F.R. (2009) Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat. Immunol. 10, 1237-1244.
87. Sung, S.S., Fu, S.M., Rose, Jr, C.E., Gaskin, F., Ju, S.T. and Beaty, S.R. (2006) A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J. Immunol. 176, 2161-2172.
88. Henri, S., Vremec, D., Kamath, A., Waithman, J., Williams, S., Benoist, C. et al. (2001) The dendritic cell populations of mouse lymph nodes. J. Immunol. 167, 741-748.
89. Hamilton-Easton, A. and Eichelberger, M. (1995) Virus-specific antigen presentation by different subsets of cells from lung and mediastinal lymph node tissues of influenza virus-infected mice. J. Virol. 69, 6359-6366.
90. GeurtsvanKessel, C.H., Willart, M.A., van Rijt, L.S., Muskens, F., Kool, M., Baas, C. et al. (2008) Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells. J. Exp. Med. 205, 1621-1634.
91. Ho, A.W., Prabhu, N., Betts, R.J., Ge, M.Q., Dai, X., Hutchinson, P.E. et al. (2011) Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells. J. Immunol. 187, 6011-6021.
92. Hao, X., Kim, T.S. and Braciale, T.J. (2008) Differential response of respiratory dendritic cell subsets to influenza virus infection. J. Virol. 82, 4908-4919.
93. Helft, J., Manicassamy, B., Guermonprez, P., Hashimoto, D., Silvin, A., Agudo, J. et al. (2012) Cross-presenting CD103(+) dendritic cells are protected from influenza virus infection. J. Clin. Invest. 122, 4037-4047.
94. Kim, T.S. and Braciale, T.J. (2009) Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses. PLoS One 4, e4204.
95. Desch, A.N., Randolph, G.J., Murphy, K., Gautier, E.L., Kedl, R.M., Lahoud, M.H. et al. (2011) CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen. J. Exp. Med. 208, 1789-1797.
96. McGill, J., Van Rooijen, N. and Legge, K.L. (2008) Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs. J. Exp. Med. 205, 1635-1646.
97. Wolf, A.I., Buehler, D., Hensley, S.E., Cavanagh, L.L., Wherry, E.J., Kastner, P. et al. (2009) Plasmacytoid dendritic cells are dispensable during primary influenza virus infection. J. Immunol. 182, 871-879.
98. Sandbulte, M.R., Boon, A.C.M., Webby, R.J. and Riberdy, J.M. (2008) Analysis of cytokine secretion from human plasmacytoid dendritic cells infected with H5N1 or low-pathogenicity influenza viruses. Virology 381, 22-28.
99. Langlois, R.A. and Legge, K.L. (2010) Plasmacytoid dendritic cells enhance mortality during lethal influenza infections by eliminating virus-specific CD8 T cells. J. Immunol. 184, 4440-4446.
100. Kaminski, M.M., Ohnemus, A., Cornitescu, M. and Staeheli, P. (2012) Plasmacytoid dendritic cells and Toll-like receptor 7-dependent signalling promote efficient protection of mice against highly virulent influenza A virus. J. Gen. Virol. 93 (Pt 3), 555-559.
101. Hufford, M.M., Kim, T.S., Sun, J. and Braciale, T.J. (2011) Antiviral CD8+ T cell effector activities in situ are regulated by target cell type. J. Exp. Med. 208, 167-180.
102. Serbina, N.V., Salazar-Mather, T.P., Biron, C.A., Kuziel, W.A. and Pamer, E.G. (2003) TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19, 59-70.
103. Boonnak, K., Vogel, L., Orandle, M., Zimmerman, D., Talor, E. and Subbarao, K. (2013) Antigen-activated dendritic cells ameliorate influenza A infections. J. Clin. Invest. 123, 2850-2861.
104. Plantinga, M., Hammad, H. and Lambrecht, B.N. (2010) Origin and functional specializations of DC subsets in the lung. Eur. J. Immunol. 40, 2112-2118.
105. Lichtner, M., Mastroianni, C.M., Rossi, R., Russo, G., Belvisi, V., Marocco, R. et al. (2011) Severe and persistent depletion of circulating plasmacytoid dendritic cells in patients with 2009 pandemic H1N1 infection. PLoS One 6, e19872.
106. Gill, M.A., Long, K., Kwon, T., Muniz, L., Mejias, A., Connolly, J. et al. (2008) Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza virus or respiratory syncytial virus infection. J. Infect. Dis. 198, 1667-1676.
107. Buttignol, M., Pires-Neto, R., Ballarin, M., Dolhnikoff, M. and Mauad, T. (2014) CD8+ T cells, dendritic cells, mast cells and FOXP3 in the lungs of patients with severe influenza A (H1N1) infection. Eur. Respir. J. 44 (Suppl. 58), 3505.
108. Zhang, Z., Huang, T., Yu, F., Liu, X., Zhao, C., Chen, X. et al. (2015) Infectious progeny of 2009 A (H1N1) influenza virus replicated in and released from human neutrophils. Sci. Rep. 5, 17809.
109. Ivan, F.X., Tan, K.S., Phoon, M.C., Engelward, B.P., Welsch, R.E., Rajapakse, J.C. et al. (2013) Neutrophils infected with highly virulent influenza H3N2 virus exhibit augmented early cell death and rapid induction of type I interferon signaling pathways. Genomics 101, 101-112.
110. Wareing, M.D., Shea, A.L., Inglis, C.A., Dias, P.B. and Sarawar, S.R. (2007) CXCR2 is required for neutrophil recruitment to the lung during influenza virus infection, but is not essential for viral clearance. Viral Immunol. 20, 369-378.
111. Tate, M.D., Brooks, A.G. and Reading, P.C. (2008) The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice. Respir. Res. 9, 57.
112. Tate, M.D., Deng, Y.M., Jones, J.E., Anderson, G.P., Brooks, A.G. and Reading, P.C. (2009) Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J. Immunol. 183, 7441-7450.
113. Brandes, M., Klauschen, F., Kuchen, S. and Germain, R.N. (2013) A systems analysis identifies a feed-forward inflammatory circuit leading to lethal influenza infection. Cell 154, 197-212.
114. Yipp, B.G. and Kubes, P. (2013) NETosis: how vital is it? Blood 122, 2784-2794.
115. Pillai, P.S., Molony, R.D., Martinod, K., Dong, H., Pang, I.K., Tal, M.C. et al. (2016) Mx1 reveals innate pathways to antiviral resistance and lethal influenza disease. Science 352, 463-466.
116. Narasaraju, T., Yang, E., Samy, R.P., Ng, H.H., Poh, W.P., Liew, A.A. et al. (2011) Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am. J. Pathol. 179, 199-210.
117. Narayana Moorthy, A., Narasaraju, T., Rai, P., Perumalsamy, R., Tan, K.B., Wang, S. et al. (2013) In vivo and in vitro studies on the roles of neutrophil extracellular traps during secondary pneumococcal pneumonia after primary pulmonary influenza infection. Front. Immunol. 4, 56.
118. Morens, D.M., Taubenberger, J.K. and Fauci, A.S. (2008) Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 198, 962-970.
119. Palacios, G., Hornig, M., Cisterna, D., Savji, N., Bussetti, A.V., Kapoor, V. et al. (2009) Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One 4, e8540.
120. Rice, T.W., Rubinson, L., Uyeki, T.M., Vaughn, F.L., John, B.B., Miller, III, R.R. et al. (2012) Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit. Care Med. 40, 1487-1498.
121. Smith, M.W., Schmidt, J.E., Rehg, J.E., Orihuela, C.J. and McCullers, J.A. (2007) Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza. Comp. Med. 57, 82-89.
122. Kiessling, R., Klein, E., Pross, H. and Wigzell, H. (1975) Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur. J. Immunol. 5, 117-121.
123. Pegram, H.J., Andrews, D.M., Smyth, M.J., Darcy, P.K. and Kershaw, M.H. (2011) Activating and inhibitory receptors of natural killer cells. Immunol. Cell Biol. 89, 216-224.
124. Vivier, E., Tomasello, E., Baratin, M., Walzer, T. and Ugolini, S. (2008) Functions of natural killer cells. Nat. Immunol. 9, 503-510.
125. Gregoire, C., Chasson, L., Luci, C., Tomasello, E., Geissmann, F., Vivier, E. et al. (2007) The trafficking of natural killer cells. Immunol. Rev. 220, 169-182.
126. Stein-Streilein, J., Bennett, M., Mann, D. and Kumar, V. (1983) Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection. J. Immunol. 131, 2699-2704.
127. Gazit, R., Gruda, R., Elboim, M., Arnon, T.I., Katz, G., Achdout, H. et al. (2006) Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 7, 517-523.
128. Ge, M.Q., Ho, A.W., Tang, Y., Wong, K.H., Chua, B.Y., Gasser, S. et al. (2012) NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-gamma and perforin-dependent mechanisms. J. Immunol. 189, 2099-2109.
129. Verbist, K.C., Rose, D.L., Cole, C.J., Field, M.B. and Klonowski, K.D. (2012) IL-15 participates in the respiratory innate immune response to influenza virus infection. PLoS One 7, e37539.
130. Hwang, I., Scott, J.M., Kakarla, T., Duriancik, D.M., Choi, S., Cho, C. et al. (2012) Activation mechanisms of natural killer cells during influenza virus infection. PLoS One 7, e51858.
131. Nogusa, S., Ritz, B.W., Kassim, S.H., Jennings, S.R. and Gardner, E.M. (2008) Characterization of age-related changes in natural killer cells during primary influenza infection in mice. Mech. Ageing Dev. 129, 223-230.
132. Liu, B., Mori, I., Hossain, M.J., Dong, L., Takeda, K. and Kimura, Y. (2004) Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity. J. Gen. Virol. 85 (Pt 2), 423-428.
133. Stein-Streilein, J. and Guffee, J. (1986) In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. J. Immunol. 136, 1435-1441.
134. Abdul-Careem, M.F., Mian, M.F., Yue, G., Gillgrass, A., Chenoweth, M.J., Barra, N.G. et al. (2012) Critical role of NK cells in lung immunopathology during influenza infection in mice. J. Infect. Dis. 206, 167-177.
135. Zhou, G., Juang, S.W. and Kane, K.P. (2013) NK cells exacerbate the pathology of influenza virus infection in mice. Eur. J. Immunol. 43, 929-938.
136. Denney, L., Aitken, C., Li, C., Wilson-Davies, E., Kok, W., Clelland, C. et al. (2010) Reduction of natural killer but not effector CD8 T lymphocytes in three consecutive cases of severe/lethal H1N1/09 influenza A virus infection. PLoS One 5, 1-9.
137. Fox, A., Le, N.M., Horby, P., van Doorn, H.R., Nguyen, V.T., Nguyen, H.H., Nguyen, T.C., Vu, D.P., Nguyen, M.H., Diep, N.T. et al. (2012) Severe pandemic H1N1 2009 infection is associated with transient NK and T deficiency and aberrant CD8 responses. PLoS One 7, e31535.
138. Guo, X., Chen, Y., Li, X., Kong, H., Yang, S., Ye, B. et al. (2011) Dynamic variations in the peripheral blood lymphocyte subgroups of patients with 2009 pandemic H1N1 swine-origin influenza A virus infection. Virol. J. 8, 215.
139. Heltzer, M.L., Coffin, S.E., Maurer, K., Bagashev, A., Zhang, Z., Orange, J.S. and Sullivan, K.E. (2009) Immune dysregulation in severe influenza. J. Leukoc. Biol. 85, 1036-1043.
140. Jost, S., Quillay, H., Reardon, J., Peterson, E., Simmons, R.P., Parry, B.A. et al. (2011) Changes in cytokine levels and NK cell activation associated with influenza. PLoS One 6, e25060.
141. Welliver, T.P., Garofalo, R.P., Hosakote, Y., Hintz, K.H., Avendano, L., Sanchez, K. et al. (2007) Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J. Infect. Dis. 195, 1126-1136.
142. Hoang, L.T., Tolfvenstam, T., Ooi, E.E., Khor, C.C., Naim, A.N.M., Ho, E.X.P. et al. (2014) Patient-based transcriptome-wide analysis identify interferon and ubiquination pathways as potential predictors of influenza A disease severity. PloS One 9, 15.
143. Ahlenstiel, G., Martin, M.P., Gao, X., Carrington, M. and Rehermann, B. (2008) Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. J. Clin. Invest. 118, 1017-1026.
144. La, D., Czarnecki, C., El-Gabalawy, H., Kumar, A., Meyers, A.F.A., Bastien, N. et al. (2011) Enrichment of variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU patients: an exploratory study. PLoS One 6, e29200.
145. Mandelboim, O., Lieberman, N., Lev, M., Paul, L., Arnon, T., Bushkin, Y. et al. (2001) Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409, 1055-1060.
146. Glasner, A., Zurunic, A., Meningher, T., Lenac Rovis, T., Tsukerman, P., Bar-On, Y. et al. (2012) Elucidating the mechanisms of influenza virus recognition by Ncr1. PLoS One 7, e36837.
147. Arnon, T.I., Lev, M., Katz, G., Chernobrov, Y., Porgador, A. and Mandelboim, O. (2001) Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur. J. Immunol. 31, 2680-2689.
148. Achdout, H., Meningher, T., Hirsh, S., Glasner, A., Bar-On, Y., Gur, C. et al. (2010) Killing of avian and Swine influenza virus by natural killer cells. J. Virol. 84, 3993-4001.
149. Jansen, C.A., de Geus, E.D., van Haarlem, D.A., van de Haar, P.M., Londt, B.Z., Graham, S.P. et al. (2013) Differential lung NK cell responses in avian influenza virus infected chickens correlate with pathogenicity. Sci. Rep. 3, 2478.
150. Bar-On, Y., Glasner, A., Meningher, T., Achdout, H., Gur, C., Lankry, D. et al. (2013) Neuraminidase-mediated, NKp46-dependent immune-evasion mechanism of influenza viruses. Cell Rep. 3, 1044-1050.
151. Bar-On, Y., Seidel, E., Tsukerman, P., Mandelboim, M. and Mandelboim, O. (2014) Influenza virus uses its neuraminidase protein to evade the recognition of two activating NK cell receptors. J. Infect. Dis. 210, 410-418.
152. Mao, H., Tu, W., Qin, G., Law, H.K.W., Sia, S.F., Chan, P.-L. et al. (2009) Influenza virus directly infects human natural killer cells and induces cell apoptosis. J. Virol. 83, 9215-9222.
153. Guo, H., Kumar, P., Moran, T.M., Garcia-Sastre, A., Zhou, Y. and Malarkannan, S. (2009) The functional impairment of natural killer cells during influenza virus infection. Immunol. Cell Biol. 87, 579-589.
154. Owen, R.E., Yamada, E., Thompson, C.I., Phillipson, L.J., Thompson, C., Taylor, E. et al. (2007) Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells. J. Virol. 81, 11170-11178.
155. Achdout, H., Manaster, I. and Mandelboim, O. (2008) Influenza virus infection augments NK cell inhibition through reorganization of major histocompatibility complex class I proteins. J. Virol. 82, 8030-8037.
156. Hwang, I., Scott, J.M., Kakarla, T., Duriancik, D.M., Choi, S., Cho, C. et al. (2013) Activation mechanisms of natural killer cells during influenza virus infection. PLoS One 7, e51858.
157. Arimori, Y., Nakamura, R., Yamada, H., Shibata, K., Maeda, N., Kase, T. et al. (2014) Type I interferon plays opposing roles in cytotoxicity and interferon-gamma production by natural killer and CD8(+) T cells after influenza A virus infection in mice. J. Innate Immun. 6, 456-466.
158. Godfrey, D.I., Stankovic, S. and Baxter, A.G. (2010) Raising the NKT cell family. Nat. Immunol. 11, 197-206.
159. Bendelac, A., Savage, P.B. and Teyton, L. (2007) The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336.
160. Rhost, S., Sedimbi, S., Kadri, N. and Cardell, S.L. (2012) Immunomodulatory type II natural killer T lymphocytes in health and disease. Scand. J. Immunol. 76, 246-255.
161. Tessmer, M.S., Fatima, A., Paget, C., Trottein, F. and Brossay, L. (2009) NKT cell immune responses to viral infection. Expert Opin. Ther. Targets 13, 153-162.
162. Ho, L.P., Denney, L., Luhn, K., Teoh, D., Clelland, C. and McMichael, A.J. (2008) Activation of invariant NKT cells enhances the innate immune response and improves the disease course in influenza A virus infection. Eur. J. Immunol. 38, 1913-1922.
163. Kok, W.L., Denney, L., Benam, K., Cole, S., Clelland, C., McMichael, A.J. et al. (2012) Pivotal advance: invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection. J. Leukoc. Biol. 91, 357-368.
164. De Santo, C., Salio, M., Masri, S.H., Lee, L.Y., Dong, T., Speak, A.O. et al. (2008) Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J. Clin. Invest. 118, 4036-4048.
165. Ishikawa, H., Tanaka, K., Kutsukake, E., Fukui, T., Sasaki, H., Hata, A. et al. (2010) IFN-gamma production downstream of NKT cell activation in mice infected with influenza virus enhances the cytolytic activities of both NK cells and viral antigen-specific CD8(+) T cells. Virology 407, 325-332.
166. Paget, C., Ivanov, S., Fontaine, J., Blanc, F., Pichavant, M., Renneson, J. et al. (2011) Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia. J. Immunol. 186, 5590-5602.
167. Paget, C., Ivanov, S., Fontaine, J., Renneson, J., Blanc, F., Pichavant, M. et al. (2012) Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages. J. Biol. Chem. 287, 8816-8829.
168. Maazi, H., Singh, A.K., Speak, A.O., Lombardi, V., Lam, J., Khoo, B. et al. (2013) Lack of PD-L1 expression by iNKT cells improves the course of influenza A infection. PLoS One 8, e59599.
169. Kopecky-Bromberg, S.A., Fraser, K.A., Pica, N., Carnero, E., Moran, T.M., Franck, R.W. et al. (2009) Alpha-Cgalactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine 27, 3766-3774.
170. Guillonneau, C., Mintern, J.D., Hubert, F.X., Hurt, A.C., Besra, G.S., Porcelli, S. et al. (2009) Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity. Proc. Natl. Acad. Sci. U.S.A. 106, 3330-3335.
171. Lee, Y.S., Lee, K.A., Lee, J.Y., Kang, M.H., Song, Y.C., Baek, D.J. et al. (2011) An alpha-GalCer analogue with branched acyl chain enhances protective immune responses in a nasal influenza vaccine. Vaccine 29, 417-425.
172. Artiaga, B.L., Yang, G., Hackmann, T.J., Liu, Q.F., Richt, J.A., Salek-Ardakani, S. et al. (2016) Alpha-galactosylceramide protects swine against influenza infection when administered as a vaccine adjuvant. Sci. Rep. 6, 13.
173. Youn, H.J., Ko, S.Y., Lee, K.A., Ko, H.J., Lee, Y.S., Fujihashi, K. et al. (2007) A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system. Vaccine 25, 5189-5198.
174. Kamijuku, H., Nagata, Y., Jiang, X., Ichinohe, T., Tashiro, T., Mori, K. et al. (2008) Mechanism of NKT cell activation by intranasal coadministration of alpha-galactosylceramide, which can induce cross-protection against influenza viruses. Mucosal Immunol 1, 208-218.
175. Artis, D. and Spits, H. (2015) The biology of innate lymphoid cells. Nature 517, 293-301.
176. Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J.P., Eberl, G. et al. (2013) Innate lymphoid cells-a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145-149.
177. Mjosberg, J.M., Trifari, S., Crellin, N.K., Peters, C.P., van Drunen, C.M., Piet, B. et al. (2011) Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat. Immunol. 12, 1055-1062.
178. Monticelli, L.A., Sonnenberg, G.F., Abt, M.C., Alenghat, T., Ziegler, C.G.K., Doering, T.A. et al. (2011) Innate lymphoid cells promote lung tissue homeostasis following acute influenza virus infection. Nat. immunol. 12, 1045-1054.
179. Chang, Y.-J., Kim, H.Y., Albacker, L.A., Baumgarth, N., McKenzie, A.N.J., Smith, D.E. et al. (2011) Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 12, 631-638.
180. Gorski, S.A., Hahn, Y.S. and Braciale, T.J. (2013) Group 2 innate lymphoid cell production of IL-5 is regulated by NKT cells during influenza virus infection. PLoS Pathog 9, e1003615.
181. Tilloy, F., Treiner, E., Park, S.H., Garcia, C., Lemonnier, F., de la Salle, H. et al. (1999) An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals. J. Exp. Med. 189, 1907-1921.
182. Treiner, E. and Lantz, O. (2006) CD1d- and MR1-restricted invariant T cells: of mice and men. Curr. Opin. Immunol. 18, 519-526.
183. Walker, L.J., Kang, Y.H., Smith, M.O., Tharmalingham, H., Ramamurthy, N., Fleming, V.M. et al. (2012) Human MAIT and CD8aa cells develop from a pool of type-17 precommitted CD8+ T cells. Blood 119, 422-433.
184. Huang, S., Gilfillan, S., Cella, M., Miley, M.J., Lantz, O., Lybarger, L. et al. (2005) Evidence for MR1 antigen presentation to mucosal-associated invariant T cells. J. Biol. Chem. 280, 21183-21193.
185. Reantragoon, R., Corbett, A.J., Sakala, I.G., Gherardin, N.A., Furness, J.B., Chen, Z. et al. (2013) Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. J. Exp. Med. 210, 2305-2320.
186. Ussher, J.E., Bilton, M., Attwod, E., Shadwell, J., Richardson, R., de Lara, C. et al. (2014) CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner. Eur. J. Immunol. 44, 195-203.
187. Kurioka, A., Ussher, J.E., Cosgrove, C., Clough, C., Fergusson, J.R., Smith, K. et al. (2015) MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets. Mucosal Immunol 8, 429-440.
188. van Wilgenburg, B., Scherwitzl, I. and Hutchinson, E.C. (2016) MAIT cells are activated during human viral infections. Nat. Commun. 7, 11653.
189. Loh, L., Wang, Z., Sant, S., Koutsakos, M., Jegaskanda, S., Corbett, A.J. et al. (2016) Human mucosal-associated invariant T cells contribute to antiviral influenza immunity via IL-18-dependent activation. Proc. Natl. Acad. Sci. U.S.A. 113, 10133-10138.
190. Ivanov, S., Paget, C. and Trottein, F. (2014) Role of non-conventional T lymphocytes in respiratory infections: the case of the pneumococcus. PLoS Pathog. 10, e1004300 .